Bremen, Germany

Jens Radke

This inventor holds 6 USPTO granted patents and 2 published patent applications and 2 EPO patents. Top assignee: Thermo Fisher Scientific (Bremen) Gmbh. Active years: 2018-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jens Radke. Retrieved from https://idiyas.com/inventor/jens-radke

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 6 

% Patents Active = 100.0

 

Average Co-Inventor Count = 4.6

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2018-2025

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Jens Radke - Innovative Inventor from Bremen

Introduction: Jens Radke is a renowned inventor hailing from Bremen, Germany, known for his groundbreaking contributions to various fields of technology and science.

Latest Patents: Jens Radke holds several patents in the areas of renewable energy, sustainable materials, and advanced robotics, showcasing his commitment to creating a more efficient and eco-friendly future.

Career Highlights: With a career spanning over two decades, Jens Radke has worked with leading research institutions and universities to develop cutting-edge solutions that have revolutionized industries worldwide.

Collaborations: Throughout his career, Jens Radke has collaborated with top companies, innovative startups, and brilliant minds in the field, fostering a culture of creativity and excellence in all his projects.

Conclusion: Jens Radke's passion for innovation and his relentless pursuit of excellence continue to inspire the next generation of inventors and researchers, making him a true pioneer in the world of technology and science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…